renata1
$NSRX In September 2026 Nasus announced FDA clearance to initiate a clinical study of NS002 for anaphylaxis.
This is a meaningful regulatory milestone, but it is not FDA marketing approval.<<
About NSRX
Bearish Sentiment
How do you feel about NSRX?